FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109525012> ?p ?o ?g. }

• W2109525012 endingPage "1044" @default.
• W2109525012 startingPage "1037" @default.
• W2109525012 abstract "Abstract Background and Aims: AG490, the specific inhibitor of JAK2/STAT3 signaling, has been shown to decrease portal pressure, splanchnic hyperdynamic circulation and liver fibrosis in cirrhotic rats. Nonselective betablockers such as propranolol are the only drugs recommended in the treatment of portal hypertension. The aim of this study was to explore the combinative effect of treatment with propranolol and AG490 on portal hypertension. Methods: Rats induced by common bile duct ligation were treated with vehicle, AG490, propranolol, or AG490 + propranolol for 2 weeks. Hemodynamics parameters were assessed. Expressions of phospho‐STAT3 protein and its down‐regulated cytokines in splanchnic organs were detected by ELISA or western blot. Lipopolysaccharide binding protein (LBP) and IL‐6 were assessed by ELISA or western blot. Characterization of liver and mesentery was performed by histological analyses. Results: Highly expressed phospho‐STAT3 protein in cirrhotic rats could successfully be inhibited by AG490 or AG490 + propranolol treatments but not by propranolol alone. Both AG490 and propranolol significantly reduced portal pressure and hyperdynamic splanchnic circulation, and combination of AG490 and propranolol achieved an additive effect than with either drug alone. AG490, alone or in combination with propranolol, inhibited liver fibrosis, splenomegaly and splanchnic angiogenesis. Increased markers of bacterial translocation (LBP and IL6) were greatly reduced by propranolol but not by AG490. Conclusions: The combination of propranolol and AG490 caused a greater improvement of portal hypertension and might therefore offer a potentially promising therapy in the portal hypertension treatment." @default.
• W2109525012 created "2016-06-24" @default.
• W2109525012 creator A5005441350 @default.
• W2109525012 creator A5012851930 @default.
• W2109525012 creator A5018279850 @default.
• W2109525012 creator A5036845831 @default.
• W2109525012 creator A5046454314 @default.
• W2109525012 creator A5072315367 @default.
• W2109525012 creator A5089620708 @default.
• W2109525012 date "2016-04-28" @default.
• W2109525012 modified "2023-10-03" @default.
• W2109525012 title "Combined administration of propranolol + AG490 offers better effects on portal hypertensive rats with cirrhosis" @default.
• W2109525012 cites W1528591039 @default.
• W2109525012 cites W1965709993 @default.
• W2109525012 cites W1968333663 @default.
• W2109525012 cites W1978153944 @default.
• W2109525012 cites W1980408510 @default.
• W2109525012 cites W1986332326 @default.
• W2109525012 cites W1990139802 @default.
• W2109525012 cites W1995876098 @default.
• W2109525012 cites W199832027 @default.
• W2109525012 cites W2019122252 @default.
• W2109525012 cites W2025077770 @default.
• W2109525012 cites W2026071229 @default.
• W2109525012 cites W2033338195 @default.
• W2109525012 cites W2042043279 @default.
• W2109525012 cites W2042856155 @default.
• W2109525012 cites W2048772681 @default.
• W2109525012 cites W2049864335 @default.
• W2109525012 cites W2056894900 @default.
• W2109525012 cites W2071679347 @default.
• W2109525012 cites W2080766557 @default.
• W2109525012 cites W2082281323 @default.
• W2109525012 cites W2083469788 @default.
• W2109525012 cites W2085407581 @default.
• W2109525012 cites W2097100895 @default.
• W2109525012 cites W2097299877 @default.
• W2109525012 cites W2104643495 @default.
• W2109525012 cites W2105690348 @default.
• W2109525012 cites W2107590848 @default.
• W2109525012 cites W2134267673 @default.
• W2109525012 cites W2136275747 @default.
• W2109525012 cites W2147223665 @default.
• W2109525012 cites W2158501924 @default.
• W2109525012 cites W2168846697 @default.
• W2109525012 cites W2171716651 @default.
• W2109525012 cites W2182172152 @default.
• W2109525012 doi "https://doi.org/10.1111/jgh.13207" @default.
• W2109525012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26487394" @default.
• W2109525012 hasPublicationYear "2016" @default.
• W2109525012 type Work @default.
• W2109525012 sameAs 2109525012 @default.
• W2109525012 citedByCount "13" @default.
• W2109525012 countsByYear W21095250122017 @default.
• W2109525012 countsByYear W21095250122018 @default.
• W2109525012 countsByYear W21095250122020 @default.
• W2109525012 countsByYear W21095250122021 @default.
• W2109525012 countsByYear W21095250122022 @default.
• W2109525012 countsByYear W21095250122023 @default.
• W2109525012 crossrefType "journal-article" @default.
• W2109525012 hasAuthorship W2109525012A5005441350 @default.
• W2109525012 hasAuthorship W2109525012A5012851930 @default.
• W2109525012 hasAuthorship W2109525012A5018279850 @default.
• W2109525012 hasAuthorship W2109525012A5036845831 @default.
• W2109525012 hasAuthorship W2109525012A5046454314 @default.
• W2109525012 hasAuthorship W2109525012A5072315367 @default.
• W2109525012 hasAuthorship W2109525012A5089620708 @default.
• W2109525012 hasConcept C104317684 @default.
• W2109525012 hasConcept C126322002 @default.
• W2109525012 hasConcept C178853913 @default.
• W2109525012 hasConcept C2775849017 @default.
• W2109525012 hasConcept C2776415932 @default.
• W2109525012 hasConcept C2777214474 @default.
• W2109525012 hasConcept C2778151854 @default.
• W2109525012 hasConcept C2778808290 @default.
• W2109525012 hasConcept C2779065481 @default.
• W2109525012 hasConcept C55493867 @default.
• W2109525012 hasConcept C56900294 @default.
• W2109525012 hasConcept C71924100 @default.
• W2109525012 hasConcept C86803240 @default.
• W2109525012 hasConcept C90924648 @default.
• W2109525012 hasConcept C98274493 @default.
• W2109525012 hasConceptScore W2109525012C104317684 @default.
• W2109525012 hasConceptScore W2109525012C126322002 @default.
• W2109525012 hasConceptScore W2109525012C178853913 @default.
• W2109525012 hasConceptScore W2109525012C2775849017 @default.
• W2109525012 hasConceptScore W2109525012C2776415932 @default.
• W2109525012 hasConceptScore W2109525012C2777214474 @default.
• W2109525012 hasConceptScore W2109525012C2778151854 @default.
• W2109525012 hasConceptScore W2109525012C2778808290 @default.
• W2109525012 hasConceptScore W2109525012C2779065481 @default.
• W2109525012 hasConceptScore W2109525012C55493867 @default.
• W2109525012 hasConceptScore W2109525012C56900294 @default.
• W2109525012 hasConceptScore W2109525012C71924100 @default.
• W2109525012 hasConceptScore W2109525012C86803240 @default.
• W2109525012 hasConceptScore W2109525012C90924648 @default.
• W2109525012 hasConceptScore W2109525012C98274493 @default.
• W2109525012 hasIssue "5" @default.

• next